Diagnosis of limb-girdle muscular dystrophy 2A by immunohistochemical techniques

Neuropathology

Volumn 28, Issue 3, 2008, Pages 264-268

  Kolski, Hanna K ^a,e   Hawkins, Cynthia ^b   Zatz, Mayana ^c   De Paula, Flavia ^c   Biggar, Doug ^d   Alman, Ben ^b   Vajsar, Jiri ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d HOLLAND BLOORVIEW KIDS REHABILITATION HOSPITAL   (Canada)

^e Aberhart Centre   (Canada)

Author keywords

Calpain 3; Immunohistochemistry; Limb girdle muscular dystrophy 2A; Myopathy; Western blot

Indexed keywords

CALPAIN 3;

ARTICLE; DIAGNOSTIC VALUE; EVALUATION; EXON; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIMB GIRDLE MUSCULAR DYSTROPHY; LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2A; PRIORITY JOURNAL; SCREENING TEST; TISSUE SECTION; WESTERN BLOTTING;

ADOLESCENT; BLOTTING, WESTERN; CALPAIN; CHILD; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 43049113177     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2007.00871.x     Document Type: Article

References (19)

1. Zatz M, Starling A. Calpains and disease. N Engl J Med 2005 9 : 2413 2423.
2. Chae J, Minami N, Jin Y et al. Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy. Neuromuscul Disord 2001 11 : 547 555.
3. de Paula F, Vainzof M, Passos-Bueno MR et al. Clinical variability in calpainopathy: what makes the difference? Eur J Hum Genet 2002 10 : 825 832.
4. Dincer P, Leturcq F, Richard I et al. A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey. Ann Neurol 1997 42 : 222 229.
5. Fanin M, Nascimbeni AC, Fulizio L, Angelini C. The frequency of limb girdle muscular dystrophy 2A in northeastern Italy. Neuromuscul Disord 2005 15 : 218 224.
6. Topaloglu H, Dincer P, Richard I et al. Calpain-3 deficiency causes a mild muscular dystrophy in childhood. Neuropediatrics 1997 28 : 212 216.
7. Anderson LV, Davison K, Moss JA et al. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am J Pathol 1998 153 : 1169 1179.
8. Fanin M, Fulizio L, Nascimbeni AC et al. Molecular diagnosis in LGMD2A: mutation analysis or protein testing? Hum Mutat 2004 24 : 52 62.
9. Ibi T, Jing L, Nakao N, Minami N, Sahashi K. A case of LGMD2A identified with both western blot analysis and immunostaining of calpain 3 in biopsied muscle (in Japanese with English abstract). Rinsho Shinkeigaku 2000 40 : 1023 1027.
10. Beckmann JS, Bushby KM. Advances in the molecular genetics of the limb-girdle type of autosomal recessive progressive muscular dystrophy. Curr Opin Neurol 1996 9 : 389 393.
11. Saenz A, Leturcq F, Cobo AM et al. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain 2005 128 : 732 742.
12. Keira Y, Noguchi S, Minami N, Hayashi YK, Nishino I. Localization of calpain 3 in human skeletal muscle and its alteration in limb-girdle muscular dystrophy 2A muscle. J Biochem (Tokyo) 2003 133 : 659 664.
13. Raynaud F, Fernandez E, Coulis G et al. Calpain 1-titin interactions concentrate calpain 1 in the Z-band edges and in the N2-line region within the skeletal myofibril. FEBS J 2005 272 : 2578 2590.
14. Fanin M, Pegoraro E, Matsuda-Asada C, Brown RH Jr, Angelini C. Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathy. Neurology 2001 56 : 660 665.
15. Fanin M, Nascimbeni AC, Fulizio L, Trevisan CP, Meznaric-Petrusa M, Angelini C. Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression. Am J Pathol 2003 163 : 1929 1936.
16. Pogue R, Anderson LV, Pyle A et al. Strategy for mutation analysis in the autosomal recessive limb-girdle muscular dystrophies. Neuromuscul Disord 2001 11 : 80 87.
17. Anderson LV, Davison K. Multiplex Western blotting system for the analysis of muscular dystrophy proteins. Am J Pathol 1999 154 : 1017 1022.
18. Vainzof M, Anderson LV, McNally EM et al. Dysferlin protein analysis in limb-girdle muscular dystrophies. J Mol Neurosci 2001 17 : 71 80.
19. Hackman P, Vihola A, Haravuori H et al. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet 2002 71 : 492 500.